SlideShare a Scribd company logo
One Compartment
Model
IV Infusion
LAKSHMI CHANDRAN
PHARM D
SRM COLLEGE OF PHARMACY
Intravenous infusion
When a drug is administered intravenously at a constant rate (zero order) over a long period of time ,
it is known as IV infusion. The duration of the constant rate infusion is much longer than the half life of
the drug. E.g. antibiotics, theophylline, procainamide etc.
Why IV infusion?
•When the drug has potential to precipitate toxicity
•When a stable concentration of the drug is to be maintained for the therapeutic effect.
Advantages
•Ease of control of rate of infusion to fit individual patient needs.
•Prevents fluctuating maxima and minima (peak and valley) plasma level, desired especially when the
drug has a narrow therapeutic index.
•Other drugs, electrolytes and nutrients can be conveniently administered simultaneously by the same
infusion line in critically ill patients.
Zero - Order
Kinetics
The rate of change in concentration is expressed as :
𝒅𝑪
𝒅𝒕
= - K . Cn where n is the order of the reaction
for zero order kinetics n=0
𝒅𝑪
𝒅𝒕
= - K0 C0 = - K0 ( zero order rate constant in mg/min)
Rearranging the equation we get:
dC= - K0 t
Integrating both sides
C-C0= - K0 t
C= C0 - K0 t
C0 is conc of drug at t=0
C is conc of drug yet to
Undergo reaction at time t
Zero order processes can be defined
as the one whose rate is independent
of the concentration of drug
undergoing reaction i.e. the rate
cannot be increased further by
increasing the concentration of
reactants.
IV Infusion Model
DRUG
BLOOD AND OTHER
BODY TISSUES
ELIMINATION
R0 KE
Zero-order
Infusion rate
R0- Zero order infusion rate
KE- Elimination rate constant
At any time during infusion , the rate of change in the amount of drug in the body, dX/dt is the difference between
the zero order rate of drug infusion R0 and first order rate of elimination, -KEX
𝑑𝑋
𝑑𝑡
= R0 – KEX - (1)
Integrating eq.(1) yields
X =
𝑅0
𝐾 𝐸
(1- 𝑒−𝐾𝐸𝑡) - (2)
Since X= Vd.C where Vd is the volume of distribution and C is the Conc. of drug, eq. (2) can be transformed as:
C =
𝑅0
𝐾 𝐸
𝑉 𝑑
(1- 𝑒−𝐾𝐸𝑡 ) =
𝑅0
𝐶𝑙 𝑇
(1- 𝑒−𝐾𝐸𝑡 ) - (3)
Plasma concentration – Time profile
1. Initially the drug enters the body at
constant rate
2. The infusion rate R0 > KEX (elimination
rate).
3. As infusion time progresses the rate of
infusion equalizes with the elimination rate
of the drug
4. This stage is called the steady state
concentration /plateau/ infusion
equilibrium. (CSS )
5. At this stage concentration of drug in
plasma approaches a constant value.
At steady state , the rate of change of amount of drug in the body is zero, hence the eq. (1) becomes:
𝑑𝑋
𝑑𝑡
= R0 – KEX -(1)
0= R0 – KEXSS
R0 = KEXSS - (4)
Transforming to concentration terms and rearranging the equation:
CSS =
𝑅0
𝐾 𝐸
𝑉 𝑑
=
𝑅0
𝐶𝑙 𝑇
𝑖𝑛𝑓𝑢𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑒
𝑐𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒
- (5)
KE- Elimination rate constant
CSS- Concentration of the drug at steady state
XSS- Amount of the drug in the body at steady state
Calculating KE by using semi logarithmic
plot
Alternative method : During infusion the KE
can be calculated:
𝑅0
𝐶𝑙 𝑇
= CSS -(5)
C= CSS (1-𝑒−𝐾𝐸𝑡) - (6)
[𝐶 𝑆𝑆
−𝐶
𝐶 𝑆𝑆
] = 𝑒−𝐾𝐸𝑡 - (7)
log [𝐶 𝑆𝑆
−𝐶
𝐶 𝑆𝑆
] = −𝐾𝐸𝑡
2.303
- (8)
Half life of drug in IV infusion
•The time to reach steady state concentration is
dependent upon the elimination half life and
not on the infusion rate.
•If n is the number of half lives passed since the
start of infusion, the eq. (6) can be written as:
C= CSS {1- ( 𝟏
𝟐) n }
Where C is the concentration of the drug after
nth half life
•The percent of CSS achieved at the end of each
half life is the sum of CSS at previous half life
and the concentration of drug remaining after
a given half life
Half life % remaining % CSS achieved
1 50 50
2 25 50+25=75
3 12.5 75+ 12.5= 87.5
4 6.25 87.5+ 6.25= 93.75
5 3.125 93.75+ 3.125= 96.875
6 1.562 96.875+ 1.562= 98.437
7 0.781 98.437+ 0.781= 99.218
For therapeutic purpose, more than 90% of CSS is desired
which is reached in 3.3 half lives. It takes 6.6 half lives to
reach 99% of CSS. Shorter the half life, sooner the CSS
reached. E.g. Penicillin G with half life of 30 mins.
Infusion plus Loading Dose
What is loading dose?
•For drugs having longer half lives, like phenobarbital (5 days), it takes longer time to achieve the
steady state concentration. To overcome the sub therapeutic concentration of these drugs, an IV
loading dose large enough is administered to reach the steady state immediately
•After the loading dose is administered, the IV infusion is given immediately at a rate enough to
maintain this concentration.
Some important drugs that require loading dose:
• Amiodarone- Loading dose of 150 mg IV in 10 minutes slowly, followed by IV infusion of 540 mg over
18 hours.
•Streptokinase- Loading dose of 250,000 IU, followed by IV infusion of 100,000 IU/hr for 72 hours for
recurring pulmonary emboli and DVT.
•Succinylcholine- Loading dose of 0.3-1.1 mg/kg over 30 sec for surgical procedures and a continuous
IV infusion of 0.5-1.0 mg/min for prolonged muscle relaxation.
Calculating the loading dose
X= Vd.C
Taking X0,L as the loading dose,
X0,L= CSS. Vd - (9)
Substituting CSS= R0/ KEVd in eq. (9)
X0,L=
𝑹 𝟎
𝑲 𝑬
- (10)
Hence the eq. describing the plasma conc.
Following the IV loading dose and IV infusion
is:
C=
X0,L
Vd
𝒆−𝑲𝑬𝒕 +
𝑹 𝟎
𝑲 𝑬
𝑽 𝒅
(1-𝒆−𝑲𝑬𝒕) - (11)
Assessment of Pharmacokinetic
Parameters
•Apparent volume of distribution
Vd =
𝑹 𝟎
𝑲 𝑬
.𝑪𝑺𝑺
•Total systemic clearance
ClT =
𝑹 𝟎
𝑪 𝑺𝑺
•These two parameters can also be calculated from the total area under the curve (AUC) till the
end of infusion:
AUC =
𝑹 𝟎
𝑻
𝑲 𝑬
𝑽 𝒅
=
𝑹 𝟎
𝑻
ClT
= CSS. T
Where T is the infusion time.
References:
•Biopharmaceutics and Pharmacokinetics by D. M. Brahmankar and Sunil B. Jaiswal
•Guidance on Drug Doses Loading Doses for Primary Care Health Care Professionals by NHS
http://www.southernhealth.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=30182

More Related Content

What's hot

Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
Debasish Ghadei
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
PreetiPatilVibhute
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
DR. METI.BHARATH KUMAR
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
Hirepravin
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
Malla Reddy College of Pharmacy
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
PriyankaDabirBharadk
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
Naresh Gorantla
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
pratiksha Pratiksha
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesis
Zahid1392
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
SURYAKANTVERMA2
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
DR. METI.BHARATH KUMAR
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
shikha singh
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
Pallavi Kurra
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkar
Sneha Gaurkar
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
PRASHANT DEORE
 

What's hot (20)

Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesis
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 
Pharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosingPharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosing
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkar
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 

Similar to One compartment model IV Infusion

iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
MuhammadAhmadPharmD
 
one compartment open model
one compartment open modelone compartment open model
one compartment open model
SUJITHA MARY
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.ppt
Noorelhuda2
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
สมชาย ญาณโรจนะ
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
PNMallikarjun
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
Pharmacokinetics of IV infusion, one-compartment open model
Pharmacokinetics of IV infusion, one-compartment open modelPharmacokinetics of IV infusion, one-compartment open model
Pharmacokinetics of IV infusion, one-compartment open model
Asuprita Patel
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
Md. Mohabbot Hossen
 
Dosage regimen
Dosage regimenDosage regimen
05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt
Noorelhuda2
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
MdNazmulIslamTanmoy
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Areej Abu Hanieh
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
Sonia Barua
 
anshu two compartment model 2.pptx
anshu two compartment model 2.pptxanshu two compartment model 2.pptx
anshu two compartment model 2.pptx
Anshulvishwakarma10
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
SARADPAWAR1
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
rameshjanga11
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
emebetnigatu1
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusionDr.saqib habib
 
Loading dose plus iv infusion
Loading dose plus iv infusionLoading dose plus iv infusion
Loading dose plus iv infusion
Imran Ahammad Chowdhury
 
Half life ppt
Half life pptHalf life ppt
Half life ppt
kalpanatiwari17
 

Similar to One compartment model IV Infusion (20)

iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
 
one compartment open model
one compartment open modelone compartment open model
one compartment open model
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.ppt
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
Pharmacokinetics of IV infusion, one-compartment open model
Pharmacokinetics of IV infusion, one-compartment open modelPharmacokinetics of IV infusion, one-compartment open model
Pharmacokinetics of IV infusion, one-compartment open model
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
Dosage regimen
Dosage regimenDosage regimen
Dosage regimen
 
05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
 
anshu two compartment model 2.pptx
anshu two compartment model 2.pptxanshu two compartment model 2.pptx
anshu two compartment model 2.pptx
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
 
Loading dose plus iv infusion
Loading dose plus iv infusionLoading dose plus iv infusion
Loading dose plus iv infusion
 
Half life ppt
Half life pptHalf life ppt
Half life ppt
 

Recently uploaded

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 

Recently uploaded (20)

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

One compartment model IV Infusion

  • 1. One Compartment Model IV Infusion LAKSHMI CHANDRAN PHARM D SRM COLLEGE OF PHARMACY
  • 2. Intravenous infusion When a drug is administered intravenously at a constant rate (zero order) over a long period of time , it is known as IV infusion. The duration of the constant rate infusion is much longer than the half life of the drug. E.g. antibiotics, theophylline, procainamide etc. Why IV infusion? •When the drug has potential to precipitate toxicity •When a stable concentration of the drug is to be maintained for the therapeutic effect. Advantages •Ease of control of rate of infusion to fit individual patient needs. •Prevents fluctuating maxima and minima (peak and valley) plasma level, desired especially when the drug has a narrow therapeutic index. •Other drugs, electrolytes and nutrients can be conveniently administered simultaneously by the same infusion line in critically ill patients.
  • 3. Zero - Order Kinetics The rate of change in concentration is expressed as : 𝒅𝑪 𝒅𝒕 = - K . Cn where n is the order of the reaction for zero order kinetics n=0 𝒅𝑪 𝒅𝒕 = - K0 C0 = - K0 ( zero order rate constant in mg/min) Rearranging the equation we get: dC= - K0 t Integrating both sides C-C0= - K0 t C= C0 - K0 t C0 is conc of drug at t=0 C is conc of drug yet to Undergo reaction at time t Zero order processes can be defined as the one whose rate is independent of the concentration of drug undergoing reaction i.e. the rate cannot be increased further by increasing the concentration of reactants.
  • 4. IV Infusion Model DRUG BLOOD AND OTHER BODY TISSUES ELIMINATION R0 KE Zero-order Infusion rate R0- Zero order infusion rate KE- Elimination rate constant
  • 5. At any time during infusion , the rate of change in the amount of drug in the body, dX/dt is the difference between the zero order rate of drug infusion R0 and first order rate of elimination, -KEX 𝑑𝑋 𝑑𝑡 = R0 – KEX - (1) Integrating eq.(1) yields X = 𝑅0 𝐾 𝐸 (1- 𝑒−𝐾𝐸𝑡) - (2) Since X= Vd.C where Vd is the volume of distribution and C is the Conc. of drug, eq. (2) can be transformed as: C = 𝑅0 𝐾 𝐸 𝑉 𝑑 (1- 𝑒−𝐾𝐸𝑡 ) = 𝑅0 𝐶𝑙 𝑇 (1- 𝑒−𝐾𝐸𝑡 ) - (3)
  • 6. Plasma concentration – Time profile 1. Initially the drug enters the body at constant rate 2. The infusion rate R0 > KEX (elimination rate). 3. As infusion time progresses the rate of infusion equalizes with the elimination rate of the drug 4. This stage is called the steady state concentration /plateau/ infusion equilibrium. (CSS ) 5. At this stage concentration of drug in plasma approaches a constant value.
  • 7. At steady state , the rate of change of amount of drug in the body is zero, hence the eq. (1) becomes: 𝑑𝑋 𝑑𝑡 = R0 – KEX -(1) 0= R0 – KEXSS R0 = KEXSS - (4) Transforming to concentration terms and rearranging the equation: CSS = 𝑅0 𝐾 𝐸 𝑉 𝑑 = 𝑅0 𝐶𝑙 𝑇 𝑖𝑛𝑓𝑢𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 𝑐𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 - (5) KE- Elimination rate constant CSS- Concentration of the drug at steady state XSS- Amount of the drug in the body at steady state
  • 8. Calculating KE by using semi logarithmic plot Alternative method : During infusion the KE can be calculated: 𝑅0 𝐶𝑙 𝑇 = CSS -(5) C= CSS (1-𝑒−𝐾𝐸𝑡) - (6) [𝐶 𝑆𝑆 −𝐶 𝐶 𝑆𝑆 ] = 𝑒−𝐾𝐸𝑡 - (7) log [𝐶 𝑆𝑆 −𝐶 𝐶 𝑆𝑆 ] = −𝐾𝐸𝑡 2.303 - (8)
  • 9. Half life of drug in IV infusion •The time to reach steady state concentration is dependent upon the elimination half life and not on the infusion rate. •If n is the number of half lives passed since the start of infusion, the eq. (6) can be written as: C= CSS {1- ( 𝟏 𝟐) n } Where C is the concentration of the drug after nth half life •The percent of CSS achieved at the end of each half life is the sum of CSS at previous half life and the concentration of drug remaining after a given half life Half life % remaining % CSS achieved 1 50 50 2 25 50+25=75 3 12.5 75+ 12.5= 87.5 4 6.25 87.5+ 6.25= 93.75 5 3.125 93.75+ 3.125= 96.875 6 1.562 96.875+ 1.562= 98.437 7 0.781 98.437+ 0.781= 99.218 For therapeutic purpose, more than 90% of CSS is desired which is reached in 3.3 half lives. It takes 6.6 half lives to reach 99% of CSS. Shorter the half life, sooner the CSS reached. E.g. Penicillin G with half life of 30 mins.
  • 10. Infusion plus Loading Dose What is loading dose? •For drugs having longer half lives, like phenobarbital (5 days), it takes longer time to achieve the steady state concentration. To overcome the sub therapeutic concentration of these drugs, an IV loading dose large enough is administered to reach the steady state immediately •After the loading dose is administered, the IV infusion is given immediately at a rate enough to maintain this concentration. Some important drugs that require loading dose: • Amiodarone- Loading dose of 150 mg IV in 10 minutes slowly, followed by IV infusion of 540 mg over 18 hours. •Streptokinase- Loading dose of 250,000 IU, followed by IV infusion of 100,000 IU/hr for 72 hours for recurring pulmonary emboli and DVT. •Succinylcholine- Loading dose of 0.3-1.1 mg/kg over 30 sec for surgical procedures and a continuous IV infusion of 0.5-1.0 mg/min for prolonged muscle relaxation.
  • 11. Calculating the loading dose X= Vd.C Taking X0,L as the loading dose, X0,L= CSS. Vd - (9) Substituting CSS= R0/ KEVd in eq. (9) X0,L= 𝑹 𝟎 𝑲 𝑬 - (10) Hence the eq. describing the plasma conc. Following the IV loading dose and IV infusion is: C= X0,L Vd 𝒆−𝑲𝑬𝒕 + 𝑹 𝟎 𝑲 𝑬 𝑽 𝒅 (1-𝒆−𝑲𝑬𝒕) - (11)
  • 12. Assessment of Pharmacokinetic Parameters •Apparent volume of distribution Vd = 𝑹 𝟎 𝑲 𝑬 .𝑪𝑺𝑺 •Total systemic clearance ClT = 𝑹 𝟎 𝑪 𝑺𝑺 •These two parameters can also be calculated from the total area under the curve (AUC) till the end of infusion: AUC = 𝑹 𝟎 𝑻 𝑲 𝑬 𝑽 𝒅 = 𝑹 𝟎 𝑻 ClT = CSS. T Where T is the infusion time.
  • 13. References: •Biopharmaceutics and Pharmacokinetics by D. M. Brahmankar and Sunil B. Jaiswal •Guidance on Drug Doses Loading Doses for Primary Care Health Care Professionals by NHS http://www.southernhealth.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=30182